Clinical Trial: A Phase II Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)

U.S., July 19 -- ClinicalTrials.gov registry received information related to the study (NCT07073417) titled 'A Phase II Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)' on July 09.

Brief Summary: The aim of the study is to compare the efficacy and safety of XW003 injection versus semaglutide injection in Chinese adults with obesity

Study Start Date: Aug. 01

Study Type: INTERVENTIONAL

Condition: Obesity Weight Management

Intervention: DRUG: XW003 injection

Subcutaneous injection

DRUG: semaglutide injection

Subcutaneous injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Hangzhou Sciwind Biosciences Co., Ltd.

Disclaimer: Curated by HT Syndication....